Doug Jermasek
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Doug Jermasek
Doug Jermasek is recorded as Board Member at Unicycive Therapeutics, Inc. (UNCY). The proxy statement of Unicycive Therapeutics, Inc. reports total compensation of $873,346 for Doug Jermasek in fiscal 2024, including a base salary of $363,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
Unicycive Therapeutics, Inc. (UNCY)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Unicycive Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Shalabh Gupta CEO, Board Member
- John Townsend CFO, Board Member
- Gaurav Aggarwal, M.D. Board Member
- Gaurav Aggarwal, MD Board Member
- Meredith S. Manning Board Member
- Pramod Gupta Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Unicycive Therapeutics, Inc. (UNCY) | Executive VP, Corporate Strategy | $363,000 | $873,346 |
| 2023 | Unicycive Therapeutics, Inc. (UNCY) | Executive VP, Corporate Strategy | $330,000 | $1,267,854 |
| 2022 | Unicycive Therapeutics, Inc. (UNCY) | Executive VP, Corporate Strategy | $330,000 | $465,165 |
Recent activity
No call appearances or filed executive changes recorded yet.